Prosecution Insights
Last updated: April 19, 2026

AbbVie Inc.

15 pending office actions

Portfolio Summary

15
Total Pending OAs
4
Final Rejections
11
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19190045 RISANKIZUMAB COMPOSITIONS KIM, YUNSOO 1641 Non-Final OA Apr 25, 2025
19189086 RISANKIZUMAB COMPOSITIONS FAY, ZOHREH ALEMZADEH 1617 Final Rejection Apr 24, 2025
18733551 BROMODOMAIN INHIBITORS CHEN, PO-CHIH 1621 Non-Final OA Jun 04, 2024
18666929 SYSTEMS AND METHODS FOR GENERATING LONGITUDINAL DATA PROFILES FROM MULTIPLE DATA SOURCES KIM, STEVEN S 3698 Non-Final OA May 17, 2024
18572741 Degrader Compounds and Uses Thereof SHIAO, REI TSANG 1691 Non-Final OA Dec 20, 2023
18489058 DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USER FREDRICKSON, COURTNEY B 3783 Non-Final OA Oct 18, 2023
18482794 COCRYSTALS OF UPADACITINIB MOTEVALLI, OROD 1628 Non-Final OA Oct 06, 2023
18476916 METHODS OF TREATING HIDRADENITIS SUPPURATIVA RZECZYCKI, PHILLIP MATTHEW 1625 Non-Final OA Sep 28, 2023
18462918 MODULATORS OF THE INTEGRATED STRESS PATHWAY NOLAN, JASON MICHAEL 1623 Final Rejection Sep 07, 2023
18330185 MODULATORS OF THE INTEGRATED STRESS PATHWAY RICCI, CRAIG D 1611 Non-Final OA Jun 06, 2023
18330171 MODULATORS OF THE INTEGRATED STRESS PATHWAY PATEL, SAGAR S 1626 Non-Final OA Jun 06, 2023
18317725 METHODS OF TREATING HEAVY MENSTRUAL BLEEDING RICCI, CRAIG D 1611 Final Rejection May 15, 2023
17787828 Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof VALLE, ERNESTO 1623 Non-Final OA Jun 21, 2022
17733303 IL-1 Binding Proteins CANELLA, KAREN A 1643 Final Rejection Apr 29, 2022
17325900 METHODS OF TREATING HEAVY MENSTRUAL BLEEDING RICCI, CRAIG D 1611 Non-Final OA May 20, 2021

Managing AbbVie Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month